ELISA is a highly sensitive technique, where small variations may lead to erroneous results. This is why one very common question is: why is my ELISA test not working?
Read more
La investigación ha demostrado que el tratamiento con pantotenato y L-carnitina pueden mejorar significativamente el fenotipo mutante en modelos celulares y abre la posibilidad de realizar ensayos cl...
Read more
A study led by researchers from the Stem Cell and Cancer Research Group at the Hospital del Mar Medical Research Institute has revealed the key role a protein plays in identifying patients with T-cell...
Read more
BraiN20® determina qué pacientes con este tipo de ictus -que suelen ser causados por un coágulo de sangre en el cerebro- tienen más probabilidad de beneficiarse de una trombectomía mecánica, el ...
Read more
Treatment with deferiprone in patients with early Parkinson's disease who have not yet received treatment with levodopa or other dopaminergic drugs, does not provide clinical benefit and, on the contr...
Read more
Un grupo de investigadores españoles y especialistas en la visión, junto a la compañía tecnológica española Proconsi, han desarrollado la primera tecnología para tratar la intolerancia de pacie...
Read more
The study analyzes the scientific evidence on the harmful effect of environmental pollution and heavy metals on cardiovascular health and summarizes the strategies for its prevention and treatment.
Read more
Investigadores de la Universidad Politécnica de Madrid estudian la implicación de biomarcadores en la predicción de la recaída y repuesta de los pacientes del cáncer colorrectal al tratamiento qu...
Read more
Han publicado en la revista Metabolism los resultados de un ensayo clínico donde se han evaluado diferentes estrategias terapéuticas para los niveles bajos de testosterona en varones con obesidad.
Read more
It has been announced today the enrollment of the first patient in a Phase II collaborative study with iadademstat in patients with relapsed/refractory high grade neuroendocrine carcinomas (NEC).
Read more
Researchers have designed the first ‘living medicine’ to treat lung infections. The treatment targets Pseudomonas aeruginosa, a type of bacteria which is naturally resistant to many types of antib...
Read more
Minoryx Therapeutics announces that data from its Phase 2/3 ADVANCE clinical trial of lead candidate, leriglitazone, has been published in The Lancet Neurology. This trial, assessing the efficacy and ...
Read more
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del...
La revista ‘Nature Protocols’ selecciona esta técnica como “pro...
